MCRB News and Press, Seres Therapeutics Inc. From 05/09/24

A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 20.3% to $0.0699 on volume of 164,902,840 shares Safe and Green Development Corporation (SGD) rose 36.7% to $0.8477 on volume of 100,466,382 shares PROSHARES TRUST (SQQQ) fell 0.6% to $1...

2024-05-09 13:22:28 ET More on Novo Nordisk The FTC Cracks Down On Novo Nordisk's Ozempic Novo Nordisk A/S 2024 Q1 - Results - Earnings Call Presentation Novo Nordisk A/S (NVO) Q1 2024 Earnings Call Transcript Catalent, Novo Nordisk receive FTC request for mo...

A look at the top 10 most actives in the United States iSun Inc. (ISUN) rose 51.4% to $0.1998 on volume of 132,838,583 shares Reborn Coffee Inc. (REBN) rose 84.4% to $3.19 on volume of 109,626,591 shares PROSHARES TRUST (SQQQ) rose 0.2% to $10.74 on volume of 99,444,834 shares Nikola Co...

2024-05-08 12:52:00 ET More on mid-day movers & stocks. MaxCyte, Inc. (MXCT) Q4 2023 Earnings Call Transcript iSun to effect 1-for-20 reverse stock split to regain Nasdaq compliance Financial information for Davis Commodities Limited Seeking Alpha’...

A look at the top 10 most actives in the United States iSun Inc. (ISUN) rose 39.1% to $0.1836 on volume of 68,543,172 shares Reborn Coffee Inc. (REBN) rose 122.5% to $3.85 on volume of 42,107,040 shares Pineapple Energy Inc. (PEGY) rose 6.9% to $0.0809 on volume of 28,629,136 shares Nik...

2024-05-08 07:26:02 ET More on Seres Therapeutics Seres Therapeutics GAAP EPS of -$0.89 beats by $0.10, revenue of $126.33M beats by $0.23M Seeking Alpha’s Quant Rating on Seres Therapeutics Historical earnings data for Seres Therapeutics Financial inf...

Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...

Continued market adoption of VOWST® with approximately 1,411 patient enrollment forms received, approximately 1,083 new patient starts, and net sales of $10.1 million during Q1 2024, and accelerated net sales in March and April SER-155 Phase 1b placebo-controlled Cohort 2 clinical re...

2024-05-07 14:04:56 ET More on Seres Therapeutics Seres Therapeutics, Inc. (MCRB) Q4 2023 Earnings Call Transcript Seres Therapeutics GAAP EPS of -$0.89 beats by $0.10, revenue of $126.33M beats by $0.23M Seeking Alpha’s Quant Rating on Seres Therapeutics ...

Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that management will host a conference call and live audio webcast on May 8, 2024 at 8:30 a.m. ET to discuss first quarter 2024 financial results and provide business updates. To access the con...